Screener
Protalix BioTherapeutics, Inc. PLX Q3 2025 earnings
Reported November 13, 2025 · Before market open
Revenue$17.9MBeat by $3.6M
EPS$0.03Miss by $0.03
Revenue estimate$14.2M
EPS estimate$0.06
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$13.4M
EPS estimate-$0.02
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Protalix BioTherapeutics, Inc. report Q3 2025 earnings?
- Protalix BioTherapeutics, Inc. (PLX) reported Q3 2025 earnings on November 13, 2025 before market open.
- What were Protalix BioTherapeutics, Inc.'s Q3 2025 revenue and EPS?
- Protalix BioTherapeutics, Inc. reported revenue of $17.9M and eps of $0.03 for Q3 2025.
- Did Protalix BioTherapeutics, Inc. beat estimates in Q3 2025?
- Revenue beat the consensus estimate of $14.2M by $3.6M. EPS missed the consensus estimate of $0.06 by $0.03.
- How did Protalix BioTherapeutics, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 0.6% from $18.0M a year earlier and eps grew 0.0% from $0.03.
- Where can I find Protalix BioTherapeutics, Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001104659-25-110821) and the 10-Q periodic report (0001104659-25-110824) directly on SEC EDGAR. The filing index links above go to sec.gov.
